Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.43 - $0.91 $1,393 - $2,948
-3,240 Reduced 6.83%
44,185 $22,000
Q4 2021

Feb 14, 2022

SELL
$1.18 - $2.18 $5,789 - $10,695
-4,906 Reduced 9.37%
47,425 $60,000
Q3 2021

Nov 09, 2021

BUY
$1.48 - $2.35 $1,346 - $2,138
910 Added 1.77%
52,331 $117,000
Q2 2021

Aug 13, 2021

SELL
$1.87 - $2.7 $1,288 - $1,860
-689 Reduced 1.32%
51,421 $104,000
Q1 2021

May 13, 2021

BUY
$2.06 - $3.01 $83,386 - $121,841
40,479 Added 348.03%
52,110 $138,000
Q4 2020

Feb 11, 2021

SELL
$1.99 - $3.25 $8,686 - $14,186
-4,365 Reduced 27.29%
11,631 $23,000
Q3 2020

Nov 12, 2020

SELL
$2.85 - $4.1 $6,549 - $9,421
-2,298 Reduced 12.56%
15,996 $46,000
Q2 2020

Aug 12, 2020

BUY
$2.39 - $4.0 $43,722 - $73,176
18,294 New
18,294 $68,000
Q4 2019

Feb 10, 2020

SELL
$1.77 - $3.84 $177 - $384
-100 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.25 - $2.35 $125 - $235
100 New
100 $0
Q2 2018

Aug 14, 2018

SELL
$3.75 - $6.05 $1,125 - $1,815
-300 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$4.0 - $8.15 $49,200 - $100,245
-12,300 Reduced 97.62%
300 $1,000
Q4 2017

Feb 14, 2018

BUY
$6.35 - $8.75 $20,320 - $28,000
3,200 Added 34.04%
12,600 $86,000
Q3 2017

Nov 14, 2017

BUY
$5.75 - $8.1 $54,050 - $76,140
9,400
9,400 $76,000

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.